Joinn Laboratories (China) Co Ltd

603127

Company Profile

  • Business description

    Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

  • Contact

    A5 Rongjing East Street
    Beijing Economic-Technological Development Area
    Beijing100176
    CHN

    T: +86 1067869966

    https://www.joinnlabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    2,510

Stocks News & Analysis

video

Do you qualify as 'rich'?

Morningstar's Sim Mody speaks with Mark LaMonica about the varying definitions of rich. 
stocks

Solid sales from ASX healthcare leader

Solid device sales with shares moderately undervalued.
stocks

Megatrend Investing: ASX players to capitalise on the clean energy transition

Find out how you can benefit from global megatrends.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,683.4050.000.58%
CAC 407,887.0819.32-0.24%
DAX 4021,520.3314.630.07%
Dow JONES (US)44,556.04134.130.30%
FTSE 1008,594.4723.700.28%
HKSE20,597.09192.87-0.93%
NASDAQ19,654.02262.061.35%
Nikkei 22538,831.4833.110.09%
NZX 50 Index12,844.5960.45-0.47%
S&P 5006,037.880.000.00%
S&P/ASX 2008,416.9042.900.51%
SSE Composite Index3,229.4921.11-0.65%

Market Movers